Clinical aspects: specificity and mode of action of immunosuppressives.
作者信息
Currey H L
出版信息
Rheumatol Rehabil. 1976 Aug;15(3):221-3. doi: 10.1093/rheumatology/15.3.221.
PMID:9683
Abstract
摘要
相似文献
1
Clinical aspects: specificity and mode of action of immunosuppressives.
Rheumatol Rehabil. 1976 Aug;15(3):221-3. doi: 10.1093/rheumatology/15.3.221.
2
Adverse reactions to the principal drugs used in rheumatoid arthritis--a review.类风湿关节炎常用主要药物的不良反应——综述
J Rheumatol Suppl. 1978;4:85-92.
3
[Rheumatoid arthritis. Considerations on a rational therapeutic strategy].[类风湿关节炎。关于合理治疗策略的思考]
Minerva Med. 1984 Feb 28;75(8):363-74.
4
5
Levamisole - a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis?左旋咪唑——类风湿关节炎长期治疗中可能替代金制剂和青霉胺的药物？
J Rheumatol. 1981 Sep-Oct;8(5):730-40.
6
[The basic therapy of rheumatoid arthritis].[类风湿关节炎的基础治疗]
Ter Arkh. 1988;60(4):148-54.
7
8
[Rheumatoid polyarthritis].
Brux Med. 1978 Dec(12):655-61.
9
The pharmacology of antirheumatic drugs.
Agents Actions Suppl. 1984;14:153-69.
10
Are slow-acting antirheumatic drugs being given earlier in rheumatoid arthritis?慢作用抗风湿药物在类风湿关节炎中是否更早使用？
Br J Rheumatol. 1988 Dec;27(6):498-9. doi: 10.1093/rheumatology/27.6.498.
引用本文的文献
1
Serum biochemistry in relation to the action of azathioprine in rheumatoid arthritis.与硫唑嘌呤在类风湿关节炎中的作用相关的血清生物化学
Agents Actions. 1983 Jun;13(4):373-9. doi: 10.1007/BF01971492.
Zotero 插件